TWB-103

· Transwell Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TWB-103, covering 2023-07-12 to 2023-07-28. Get the full timeline:

Most recent: Clinical Trial Update: TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds [Phase 1, Phase 2]